Syngene International Ltd News

Syngene shares rise over 3% after 8 mn equity changes hand via block deal

Reports suggest promoter Biocon was likely to sell a 2 per cent stake in the company via block deals

CDMO shares under pressure; Neuland, Laurus, Syngene tank up to 12%

Thus far in the calendar year 2024 (CY24), the market price of Neuland Laboratories has zoomed 216%, Piramal Pharma (88%), Divi's Labs (53%) and Jubilant Pharmova (52%)

Syngene International Q2 results: PAT down by 8.93%, revenue drops by 2%

Syngene plans to expand its capacity and capabilities at its Bangalore and Hyderabad campuses to meet anticipated long-term demand

F&O Insights: Nifty, Bank Nifty premium rises, PCR dips; check key levels

Derivatives market update for Sept 17: The premium in Nifty Sept futures jumped to 58 pts, and Bank Nifty to 100 pts; whereas, the PCR declined to near 1 levels indicating positive to sideways trend.

F&O Cues: Premium jumps in Nifty, Bank Nifty futures; options flag caution

Derivatives market update for Sept 06: The Nifty PCR dipped from 0.74, while Bank Nifty to 0.78; reflecting a cautionary trend said Dhupesh Dhameja of SAMCO Securities. Max Financial see short buildup

F&O Cues: Options data hint more gains for Nifty; 4 stocks see long buildup

Derivative market update for Monday, Sept 02: FIIs long-short ratio in index futures rose to 2.6:1, implying 5 longs for every 2 shorts. Bandhan Bank, Syngene and Granules India see long buildup.